Pregabalin antagonizes copper-induced toxicity in the brain: In vitro and in vivo studies

NeuroSignals

Volumn 18, Issue 4, 2011, Pages 210-222

  Marmolino, D ^a   Manto, M ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b FNRS   (Belgium)

Author keywords

Copper; Glutamate; Nitric oxide; NMDA; Pregabalin; Transcription

Indexed keywords

COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; N METHYL DEXTRO ASPARTIC ACID; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PREGABALIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DOSE COMPARISON; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICRODIALYSIS; MOTOR CORTEX; NERVE CELL; NERVE CELL CULTURE; NERVE EXCITABILITY; NEUROBLASTOMA CELL; NEUROPHYSIOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; COPPER; GAMMA-AMINOBUTYRIC ACID; HUMANS; MOTOR CORTEX; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; RATS; RATS, WISTAR; TREATMENT OUTCOME;

EID: 79953653074     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322544     Document Type: Article

References (65)

1. Choi BS, Zheng W: Copper transport to the brain by the blood-brain barrier and blood- CSF barrier. Brain Res 2009; 1248: 14-21.
2. Popescu BF, Robinson CA, Rajput A, et al: Iron, copper, and zinc distribution of the cerebellum. Cerebellum 2009; 8: 74-79.
3. Gaggelli E, Kozlowski H, Valensin D, et al: Copper homeostasis and neurodegenerative disorders (Alzheimer's disease, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem Rev 2006; 106: 1995-2044.
4. Rae TD, Schmidt PJ, Pufahl RA, et al: Undetectable intracellular free copper: The requirement of a copper chaperone for superoxide dismutase. Science 1999; 284: 805-808. (Pubitemid 29291346)
5. Linder MC, Hazegh-Azam M: Copper biochemistry and molecular biology. Am J Clin Nutr 1996; 63: 797-811.
6. Tandy S, Williams M, Leggett A, et al: Nramp2 expression is associated with pHdependent iron uptake across the apical membrane of human intestinal Caco-2 cells. J Biol Chem 2000; 275: 1023-1029. (Pubitemid 30051149)
7. Lutsenko S, Efremov RG, Tsivkovskii R, Walker JM: Human copper-transporting ATPase ATP7B (the Wilson's disease protein): Biochemical properties and regulation. J Bioenerg Biomembr 2002; 34: 351-362. (Pubitemid 36055729)
8. Donnelly PS, Xiao Z, Wedd AG: Copper and Alzheimer's disease. Curr Opin Chem Biol 2007; 11: 128-133. (Pubitemid 46546475)
9. Barnham KJ, Masters CL, Bush AI: Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 2004; 3: 205-214.
10. Sokol RJ, Devereaux MW, O'Brien K, et al: Abnormal hepatic mitochondrial respiration and cytochrome C oxidase activity in rats with long-term copper overload. Gastroenterology 1993; 105: 178-187. (Pubitemid 23234034)
11. Britton RS: Metal-induced hepatotoxicity. Semin Liver Dis 1996; 16: 3-12. (Pubitemid 26130097)
12. 2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo. Ann Neurol 2004; 55: 645-653. (Pubitemid 38544324)
13. White AR, Multhaup G, Maher F, et al: The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J Neurosci 1999; 19: 9170-9179. (Pubitemid 30228069)
14. Schilsky ML: Wilson disease: Current status and the future. Biochimie 2009; 91: 1278-1281.
15. Sokol RJ, Twedt D, McKim JM Jr, et al: Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 1994; 107: 1788-1798. (Pubitemid 24357635)
16. Sternlieb I, Feldmann G: Effects of anticopper therapy on hepatocellular mitochondria in patients with Wilson's disease: An ultrastructural and stereological study. Gastroenterology 1976; 71: 457-461.
17. Wiedau-Pazos M, Goto JJ, Rabizadeh S, et al: Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996; 271: 515-518. (Pubitemid 26044472)
18. Huang X, Atwood CS, Hartshorn MA, et al: The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999; 38: 7609-7616. (Pubitemid 29289332)
19. Lu J, Zheng YL, Wu DM, et al: Trace amounts of copper induce neurotoxicity in the cholesterol- fed mice through apoptosis. FEBS Lett 2006; 580: 6730-6740. (Pubitemid 44827008)
20. Duflou H, Maenhaut W, De Reuck J: Regional distribution of potassium, calcium, and six trace elements in normal human brain. Neurochem Res 1989; 14: 1099-1112. (Pubitemid 20013040)
21. Popescu BF, Robinson CA, Chapman LD, Nichol H: Synchrotron X-ray fluorescence reveals abnormal metal distributions in brain and spinal cord in spinocerebellar ataxia: A case report. Cerebellum 2009; 8: 340-351.
22. Micheva KD, Taylor CP, Smith SJ: Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons. Mol Pharmacol 2006; 70: 467-476. (Pubitemid 44092307)
23. Biedler JL, Roffler-Tarlov S, Schachner M, et al: Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 1978; 38: 3751-3757. (Pubitemid 9045201)
24. Liang HL, Dhar SS, Wong-Riley MT: P38 mitogen- activated protein kinase and calcium channels mediate signaling in depolarization- induced activation of peroxisome proliferator- activated receptor gamma coactivator- 1alpha in neurons. J Neurosci Res 2010; 88: 640-649.
25. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
26. Alvarez S, Moldovan M, Krarup C: Acute energy restriction triggers Wallerian degeneration in mouse. Exp Neurol 2008; 212: 166-178.
27. Manto M, Laute MA: A possible mechanism for the beneficial effect of ethanol in essential tremor. Eur J Neurol 2008; 15: 697-705. (Pubitemid 351814403)
28. Cais O, Sedlacek M, Horak M, et al: Temperature dependence of NR1/NR2B NMDA receptor channels. Neuroscience 2008; 151: 428-438.
29. Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J: Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol 2007; 61: 544-551. (Pubitemid 47068136)
30. Wall M: A role for zinc in cerebellar synaptic transmission? Cerebellum 2005; 4: 224-229. (Pubitemid 43861182)
31. Kitamura Y, Iida Y, Abe J, et al. : In vivo measurement of presynaptic Zn 2+ release during forebrain ischemia in rats. Biol Pharm Bull 2006; 29: 821-823.
32. Oulad Ben Taib N, Manto M: Effects of trains of high-frequency stimulation of the premotor/ supplementary motor area on conditioned corticomotor responses in hemicerebellectomized rats. Exp Neurol 2008; 212: 157-165.
33. Molina-Luna K, Buitrago MM, Hertler B, et al: Cortical stimulation mapping using epidurally implanted thin-film microelectrode arrays. J Neurosci Meth 2007; 161: 118-125. (Pubitemid 46349257)
34. Oulad Ben Taib N, Manto M, et al: Hemicerebellectomy blocks the enhancement of cortical motor output associated with repe titive somatosensory stimulation. J Physiol (Lond) 2005; 567: 293-300.
35. Chan HW, Liu T, Verdile G, et al: Copper induces apoptosis of neuroblastoma cells via post-translational regulation of the expression of Bcl-2-family proteins and the tx mouse is a better model of hepatic than brain Cu toxicity. Int J Clin Exp Med 2008; 1: 76-88.
36. Schlief ML, Craig AM, Gitlin JD: NMDA receptor activation mediates copper homeostasis in hippocampal neurons. J Neurosci 2005; 25: 239-246. (Pubitemid 40110786)
37. Trombley PQ, Shepherd GM: Differential modulation by zinc and copper of amino acid receptors from rat olfactory bulb neurons. J Neurophysiol 1996; 76: 2536-2546. (Pubitemid 26346427)
38. Cuzzocrea S, Mazzon E, Dugo L, et al: Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma. Arthritis Rheum 2003; 48: 3544-3556. (Pubitemid 37531923)
39. Beckman JS, Beckman TW, Chen J, et al: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
40. Dedon PC, Tannenbaum SR: Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 2004; 423: 12-22. (Pubitemid 38202218)
41. Goldstein S, Lind J, Merényi G: Chemistry of peroxynitrites as compared to peroxynitrates. Chem Res 2005; 105: 2457-2470. (Pubitemid 40947953)
42. Ferrer-Sueta G, Radi R: Chemical biology of peroxynitrite: Kinetics, diffusion, and radicals. ACS Chem Biol 2009; 4: 161-177.
43. Greenwood SM, Connolly CN: Dendritic and mitochondrial changes during glutamate excitotoxicity. Neuropharmacology 2007; 53: 891-898. (Pubitemid 350137396)
44. Frykholm P, Hillered L, Langstrom B, et al: Increase of intersticial glycerol reflects the degree of ischemic brain damage: A PET and microdialysis study in a middle cerebral artery occlusion-reperfusion primate model. J Neurol Neurosurg Psychiatry 2001; 71: 455-461. (Pubitemid 32906867)
45. Dohmen C, Bosche B, Graf R, et al: Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke 2003; 34: 2152-2158. (Pubitemid 37099828)
46. Brawek B, Löffler M, Weyerbrock A, Feuerstein TJ: Effects of gabapentin and pregabalin on K + -evoked 3 H-GABA and 3 H-glutamate release from human neocortical synaptosomes. Arch Pharmacol 2009; 379: 361-369.
47. Richerson GB, Wu Y: Dynamic equilibrium of neurotransmitter transporters: Not just for reuptake anymore. J Neurophysiol 2003; 90: 1363-1374. (Pubitemid 37129348)
48. Ashcroft FM, Gribble FM: Correlating structure and function in ATP-sensitive K + channels. Trends Neurosci 1998; 21: 288-294. (Pubitemid 28293638)
49. Huang CW, Huang CC, Wu SN: The opening effect of pregabalin on ATP-sensitive potassium channels in differentiated hippocampal neuron-derived H19-7 cells. Epilepsia 2006; 47: 720-726.
50. Blanquart C, Barbier O, Fruchart J, et al: Peroxisome proliferator-activated receptors: Regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol 2003; 85: 267-273. (Pubitemid 37011102)
51. Wu Z, Puigserver P, Andersson U, et al: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999; 98: 115-124. (Pubitemid 29331201)
52. Kelly DP, Scarpulla RC: Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 2004; 18: 357-368. (Pubitemid 38316342)
53. Heneka MT, Landreth GE: PPARs in the brain. Biochim Biophys Acta 2007; 1771: 1031-1045. (Pubitemid 47208548)
54. Torchia J, Rose DW, Inostroza J, et al: The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 1997; 387: 677-684. (Pubitemid 27270601)
55. Mootha VK, Handschin C, Arlow D, et al: Erralpha and Gabpa/b specify PGC-1alphadependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci USA 2004; 101: 6570-6575. (Pubitemid 38586015)
56. St-Pierre J, Drori S, Uldry M, et al: Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006; 127: 397-408. (Pubitemid 44572377)
57. Valle I, Alvarez-Barrientos A, Arza E, et al: PGC-1{alpha} regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res 2005; 66: 562-573. (Pubitemid 40725768)
58. Liang HL, Dhar SS, Wong-Riley MT: P38 mitogen- activated protein kinase and calcium channels mediate signaling in depolarization- induced activation of peroxisome proliferator- activated receptor gamma coactivator- 1alpha in neurons. J Neurosci Res 2010; 88: 640-649.
59. 2+ channel isoforms for brain function. Biochem Soc Trans 2006; 34: 903-909. (Pubitemid 44796447)
60. Baldassa S, Zippel R, Sturani E: Depolarization- induced signaling to Ras, Rap1 and MAPKs in cortical neurons. Brain Res Mol Brain Res 2003; 119: 111-122. (Pubitemid 37324803)
61. Impey S, Obrietan K, Wong ST, et al: Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron 1998; 21: 869-883. (Pubitemid 28498794)
62. Wright DC: Mechanisms of calcium-induced mitochondrial biogenesis and GLUT4 synthes. Appl Physiol Nutr Metabol 2007; 32: 840-845.
63. Knutti D, Kralli A: PGC-1, a versatile coactivator. Trends Endocrinol Metab 2001; 12: 360-365. (Pubitemid 33714230)
64. Puigserver P, Rhee J, Lin J, et al: Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell 2001; 8: 971-982. (Pubitemid 34031800)
65. Arany Z, He H, Lin J, et al: Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 2005; 1: 259-271. (Pubitemid 43960608)